Tang Capital Management LLC Cellectar Biosciences, Inc. Transaction History

Tang Capital Management LLC

  • $819 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$10.6 - $24.1 $2.5 Million - $5.68 Million
-235,701 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$20.0 - $24.6 $8.89 Million - $10.9 Million
-444,299 Reduced 65.34%
235,701 $471,000
Q2 2019

Aug 14, 2019
BUY
$18.6 - $28.2 $12.6 Million - $19.2 Million
680,000 New
680,000 $1.48 Million

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $13M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email